Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
US Department of Justice
Dow
Fuji
Medtronic
Healthtrust
McKesson
Colorcon
Chinese Patent Office

Generated: November 18, 2018

DrugPatentWatch Database Preview

Diflorasone diacetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for diflorasone diacetate and what is the scope of diflorasone diacetate patent protection?

Diflorasone diacetate is the generic ingredient in five branded drugs marketed by Fougera Pharms, Taro, Pharmacia And Upjohn, Taro Pharms North, Akorn, Rising Pharms, and Teligent Pharma Inc, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for diflorasone diacetate. Nine suppliers are listed for this compound.

Pharmacology for diflorasone diacetate
Synonyms for diflorasone diacetate
(6alpha,11beta,16beta)-6,9-difluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl diacetate
[2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-acetoxy-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
[2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-acetyloxy-6,9-bis(fluoranyl)-10,13,16-trimethyl-11-oxidanyl-3-oxidanylidene-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxidanylidene-ethyl] ethanoate
[2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-acetyloxy-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
2-[(1R,2S,8S,10S,11S,13S,14R,15S,17S)-14-(ACETYLOXY)-1,8-DIFLUORO-17-HYDROXY-2,13,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL]-2-OXOETHYL ACETATE
33564-31-7
564D317
6alpha-Fluorobetamethasone-17,21 diacetate
6alpha,9-difluoro-11beta-hydroxy-16beta-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl diacetate
6alpha,9-Difluoro-11beta,17,21-trihydroxy-16 beta-methyl-pregna-1,4-diene-3,20-dione 17,21-diacetate
6alpha,9-Difluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-diacetate
7W2J09SCWX
A821840
AB00489907
AB2000740
AC-3515
AC1L2G4E
AC1Q62MX
acetic acid [2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-acetyloxy-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] ester
Acetic acid diflorasone
AKOS025402039
AN-6747
Apexicon e
BC226395
BCP9000608
BOBLHFUVNSFZPJ-JOYXJVLSSA-N
BPBio1_000614
BRD-K17674993-001-03-1
BRN 2318163
BSPBio_000558
CAS-33564-31-7
CCG-220619
CHEBI:31483
CHEMBL1200545
CTK8F9190
D01327
D0G7KJ
Dermaflor
Diacort
diflorasone 17,21-diacetate
Diflorasone di(acetate)
Diflorasone diacetate (JP17/USP)
Diflorasone diacetate [USAN:JAN]
Diflorasone diacetate [USAN:USP:JAN]
Diflorasone diacetate, United States Pharmacopeia (USP) Reference Standard
DSSTox_CID_25646
DSSTox_GSID_45646
DSSTox_RID_81024
DTXSID8045646
EINECS 251-575-1
Florone (TN)
Florone E
FT-0639113
GTPL7068
HMS1569L20
HMS2096L20
HMS2231D10
LS-118428
Maxiflor
MLS000069559
MLS001076548
Murode
NCGC00022003-03
NCGC00022003-04
NCGC00022003-06
Opera_ID_1660
PL000439
Pregna-1,4-diene-3,20-dione, 17,21-bis(acetyloxy)-6,9-difluoro-11-hydroxy-16-methyl-, (6alpha,11beta,16beta)-
Pregna-1,4-diene-3,20-dione, 17,21-bis(acetyloxy)-6,9-difluoro-11-hydroxy-16-methyl-,(6-alpha,11-beta,16-beta)-
Prestwick0_000619
Prestwick1_000619
Prestwick2_000619
Prestwick3_000619
Psorcon
Psorcon (TN)
Psorcon E
Q-101374
Q944
REGID_for_CID_71414
SC-80650
SCHEMBL4556
SMR000058814
SPBio_002777
SR-01000000122
SR-01000000122-3
Tox21_110875
Tox21_110875_1
U 34865
U-34,865
U-34865
UNII-7W2J09SCWX
ZINC4212938

US Patents and Regulatory Information for diflorasone diacetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms DIFLORASONE DIACETATE diflorasone diacetate CREAM;TOPICAL 076263-001 Dec 20, 2002 BX RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Taro Pharms North PSORCON diflorasone diacetate CREAM;TOPICAL 020205-001 Nov 20, 1992 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Taro DIFLORASONE DIACETATE diflorasone diacetate CREAM;TOPICAL 075508-001 Apr 24, 2000 BX RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Akorn DIFLORASONE DIACETATE diflorasone diacetate OINTMENT;TOPICAL 206572-001 Jul 24, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Rising Pharms DIFLORASONE DIACETATE diflorasone diacetate OINTMENT;TOPICAL 207440-001 Feb 27, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn PSORCON diflorasone diacetate OINTMENT;TOPICAL 019260-001 Aug 28, 1985 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for diflorasone diacetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn FLORONE diflorasone diacetate CREAM;TOPICAL 017741-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn PSORCON E diflorasone diacetate OINTMENT;TOPICAL 017994-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn PSORCON diflorasone diacetate OINTMENT;TOPICAL 019260-001 Aug 28, 1985 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn FLORONE E diflorasone diacetate CREAM;TOPICAL 019259-001 Aug 28, 1985 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
US Department of Justice
Dow
Fuji
Medtronic
Healthtrust
McKesson
Colorcon
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.